期刊文献+

血清癌胚抗原水平联合原发灶正电子发射计算机断层扫描代谢参数肿瘤代谢体积及病灶糖酵解总量对结直肠癌肝转移的预测价值 被引量:4

Predictive value of serum CEA level combined with PET/CT metabolic parameters MTV and TLG in primary liver metastases from colorectal cancer
原文传递
导出
摘要 目的分析血清癌胚抗原(CEA)水平联合原发灶正电子发射计算机断层扫描(PET/CT)代谢参数肿瘤代谢体积(MTV)及病灶糖酵解总量(TLG)对结直肠癌肝转移的预测价值.方法对2013年1月至2017年12月在浙江省人民医院行PET/CT检查的结直肠癌患者86例的临床资料进行回顾性分析,采用单因素及多因素logistic回归分析患者的临床病理参数、MTV、TLG与肝转移的关系.结果86例患者中,出现肝转移17例(19.77%).单因素分析结果发现,肝转移组T分期(χ2=8.83)、肿瘤部位(χ2=5.43)及血清CEA含量(t=11.65)与无肝转移组比较,均差异有统计学意义(均P<0.05);肝转移组TLG[(101.94±20.14)g]及MTV[(14.09±3.25)cm3]的水平较无肝转移组[(135.95±22.63)g、(25.09±4.33)cm3]明显下降(t=5.66、9.80,均P<0.01).多因素logistic回归分析结果发现,T分期(OR=3.56,95%CI:1.06~12.00)、肿瘤部位(OR=1.38,95%CI:1.05~1.81)、TLG(OR=1.68,95%CI:1.11~2.54)、MTV(OR=3.86,95%CI:1.63~9.14)及血清CEA含量(OR=2.95,95%CI:1.60~5.41)均为结直肠癌患者肝转移的影响因素(均P<0.05).结论T分期、肿瘤部位、原发灶PET/CT代谢参数(TLG、MTV)及血清CEA含量均是结直肠癌患者肝转移的影响因素,提示通过检测血清CEA水平联合原发灶PET/CT代谢参数对结直肠癌肝转移具有一定的预测价值. Objective To analyze the predictive value of serum carcinoembryonic antigen ( CEA) level combined with primary PET/CT metabolic parameters,metabolic tumor volume( MTV) and total glycolysis( TLG) in liver metastasis of colorectal cancer.Methods The clinical data of 86 patients with colorectal cancer who underwent PET/CT examination in the People's Hospital of Zhejiang Province from January 2013 to December 2017 were retrospectively analyzed.Univariate and multivariate logistic regression was used to analyze the relationship between clinicopathological parameters,MTV, TLG and liver metastasis. Results Of the 86 patients, there were 17 cases (19.77%) of liver metastases.Univariate analysis showed that there were significant differences in T stage( χ2 =8.83),tumor location(χ2 =5.43) and serum CEA content(t=11.65) between the liver metastasis group and the non-liver metastasis group(all P<0.05).The levels of TLG[(101.94 ±20.14)g] and MTV[(14.09 ±3.25)cm3] in the liver metastasis group were significantly lower than those in the non-liver metastasis group[(135.95 ± 22.63) g, (25.09 ± 4.33)cm3] ( t=5.66,9.80,all P<0.01).Multivariate logistic regression analysis showed that T stage ( OR=3.56,95%CI:1.06-12.00),tumor location(OR=1.38,95% CI:1.05-1.81),TLG(OR=1.68,95% CI: 1.11-2.54),MTV(OR=3.86,95% CI:1.63-9.14) and serum CEA( OR=2.95,95% CI:1.60-5.41) were the influencing factors of liver metastases in patients with colorectal cancer( all P<0.05).Conclusion T stage, tumor location,primary PET/CT metabolic parameters(TLG,MTV) and serum CEA levels are the influencing factors of liver metastasis in patients with colorectal cancer,suggesting that the detection of serum CEA level combined with primary PET/CT metabolic parameters has certain predictive value for liver metastasis of colorectal cancer.
作者 李中恩 程爱萍 Li Zhongen;Cheng Aiping(Department of Nuclear Medicine,the People's Hospital of Zhejiang Province (the People's Hospital Affiliated to Hangzhou Medical College),Hangzhou,Zhejiang 310014,China)
出处 《中国基层医药》 CAS 2019年第14期1674-1678,共5页 Chinese Journal of Primary Medicine and Pharmacy
基金 浙江省技术应用研究计划项目(2016C33117).
关键词 结直肠癌 肝转移 正电子发射计算机断层显像 癌胚抗原 肿瘤代谢体积 病灶糖酵解总量 多因素分析 影响因素 Colorectal cancer Liver metastasis Positron emission computed tomography Carcinoembryonic antigen Metabolic tumor volume Total glycolysis Multivariate analysis Influencing factor
  • 相关文献

参考文献9

二级参考文献61

  • 1结节病诊断及治疗方案(第三次修订稿草案)[J].中华结核和呼吸杂志,1994,17(1):9-10. 被引量:149
  • 2韩丽君,屈婉莹,潘纪戍,刘甫庚,朱明,张建飞.正电子发射计算机体层摄影-CT诊断骨转移瘤的临床价值[J].中华放射学杂志,2005,39(11):1157-1161. 被引量:14
  • 3王立东.河南食管癌研究的理解和思考[J].郑州大学学报(医学版),2006,41(1):1-5. 被引量:30
  • 4Schima W, Kulinna C, Langenberge r H, et al. Liver metastases of colorectal cancer: US, CT or MR? [J]. Cancer Imaging, 2005,23:149-156.
  • 5Garcia Vicente AM, Dominguez F erreras E, Sdnchez Perez V, et al. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET[J]. Eur J of Radiol, 2013, 82: 255-261.
  • 6Rappeport ED, Loft A, Berthelsen AK, et al. Contrastenhanced FDG-PET/CT vs. SPIO enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation [J]. Acta Radiol, 2007,48: 369-378.
  • 7Lee JW, Kim SK, Lee SM, et al. Detection of hepatic metastases using dual-timepoint FDG PET/CT scans in patients with colorectal cancer [J]. Mol Imaging Bioi, 2011,13: 565- 572.
  • 8Hamm B, Mahfouz AE, Taupitz M, et al. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? [J]. Radiology, 1997,202:677-682.
  • 9Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis- Metaanalysisj J]. Radiology, 2005,237: 123-131.
  • 10Ruers TJ, Langenhoff BS, Neeleman N, et al. Value of positron emission tomography with [F-18J fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study [J]. J Clinical Oncol, 2002,20: 388-395.

共引文献55

同被引文献40

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部